<PAGE>
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No. )
Filed by the Registrant /X/
Filed by a party other than the Registrant / /
Check the appropriate box:
/ / Preliminary Proxy Statement
/ / Confidential, for Use of the Commission Only (as permitted by Rule
14a-6(e)(2))
/ / Definitive Proxy Statement
/X/ Definitive Additional Materials
/ / Soliciting Material Pursuant to Section 240.14a-11(c) or Section
240.14a-12
Angeion Corporation / MN
- --------------------------------------------------------------------------------
(Name of Registrant as Specified In Its Charter)
- --------------------------------------------------------------------------------
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
/X/ No fee required
/ / Fee computed on table below per Exchange Act Rules 14a-6(i)(1)
and 0-11
(1) Title of each class of securities to which transaction applies:
------------------------------------------------------------------------
(2) Aggregate number of securities to which transaction applies:
------------------------------------------------------------------------
(3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined):
------------------------------------------------------------------------
(4) Proposed maximum aggregate value of transaction:
------------------------------------------------------------------------
(5) Total fee paid:
------------------------------------------------------------------------
/ / Fee paid previously with preliminary materials.
/ / Check box if any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number,
or the Form or Schedule and the date of its filing.
(1) Amount Previously Paid:
------------------------------------------------------------------------
(2) Form, Schedule or Registration Statement No.:
------------------------------------------------------------------------
(3) Filing Party:
------------------------------------------------------------------------
(4) Date Filed:
------------------------------------------------------------------------
<PAGE>
January 14, 2000
Dear:
As the newly appointed President and Chief Executive of Angeion Corporation, I
would like to take this opportunity to introduce myself. Previously, I was the
President and CEO of Medical Graphics Corporation (which Angeion acquired in
December 1999). Prior to joining Medical Graphics in August of 1998, I had
served as President and COO of CNS, Inc. I have also held executive and senior
management positions in both small emerging companies and large corporations
including ADC Telecommunications and 3M Company.
I have assumed leadership of the Company at a time in its history that is both
difficult and exciting -- difficult due to the intricacy and complexity of the
transactions in which the Company is currently involved, and exciting in that
once these necessary moves are accomplished, we will be positioned to grow the
Company from Medical Graphics' profitable base business operations.
I am writing to you personally to offer you my assistance in making a voting
decision on your Angeion shares. The proxy materials for the Annual Meeting of
Shareholders that has been adjourned to January 19, 2000 are necessarily
complicated. However, resolutions 2 and 3 are particularly important matters
since they offer the opportunity to reduce the number of shares outstanding and
to add approximately $9 million in cash to the Company. As discussed in the
proxy materials, the transactions authorized by these resolutions will
effectively increase your ownership percentage and increase the book value of
the Company at the time these transactions are closed.
I am concerned that as of January 13th, we have not received your vote. Perhaps
you may have questions that I might answer. I will therefore be trying to reach
you by phone over the next few days to discuss your vote. In the interim, please
feel free to contact me if you wish at 1-800-950-5597. Please tell the
receptionist that you are a shareholder responding to my letter.
You will shortly be receiving another mailgram with instructions enabling you to
vote by phone. Please help us avoid the considerable expense of further
solicitations and mailings by voting your shares at your earliest convenience.
Thank you for your cooperation and continued support.
Sincerely,
/s/ Richard E. Jahnke
Richard E. Jahnke
President and CEO
Angeion Corporation
